Mammalian prions cause fatal neurodegenerative conditions including Creutzfeldt–Jakob disease in humans and scrapie and bovine spongiform encephalopathy in animals1. Prion infections are typically associated with remarkably prolonged but highly consistent incubation periods followed by a rapid clinical phase. The relationship between prion propagation, generation of neurotoxic species and clinical onset has remained obscure. Prion incubation periods in experimental animals are known to vary inversely with expression level of cellular prion protein. Here we demonstrate that prion propagation in brain proceeds via two distinct phases: a clinically silent exponential phase not rate-limited by prion protein concentration which rapidly reaches a maximal prion titre, followed by a distinct switch to a plateau phase. The latter determines time to clinical onset in a manner inversely proportional to prion protein concentration. These findings demonstrate an uncoupling of infectivity and toxicity. We suggest that prions themselves are not neurotoxic but catalyse the formation of such species from PrPC. Production of neurotoxic species is triggered when prion propagation saturates, leading to a switch from autocatalytic production of infectivity (phase 1) to a toxic (phase 2) pathway.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519–550 (2001)
Griffith, J. S. Self-replication and scrapie. Nature 215, 1043–1044 (1967)
Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144 (1982)
Gajdusek, D. C. Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β- pleated sheet configurations. J. Neuroimmunol. 20, 95–110 (1988)
Come, J. H., Fraser, P. E. & Lansbury, P. T. J. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959–5963 (1993)
Collinge, J. & Clarke, A. A general model of prion strains and their pathogenicity. Science 318, 930–936 (2007)
Collinge, J. et al. Kuru in the 21st century–an acquired human prion disease with very long incubation periods. Lancet 367, 2068–2074 (2006)
Scott, M. et al. Transgenic mice expressing hamster prion protein produce species- specific scrapie infectivity and amyloid plaques. Cell 59, 847–857 (1989)
Büeler, H. et al. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19–30 (1994)
Hill, A. F. et al. Species barrier independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248–10253 (2000)
Hill, A. F. & Collinge, J. Subclinical prion infection. Trends Microbiol. 11, 578–584 (2003)
Dickinson, A. G., Meikle, V. M. & Fraser, H. Genetical control of the concentration of ME7 scrapie agent in the brain of mice. J. Comp. Pathol. 79, 15–22 (1969)
Dickinson, A. G. Host-pathogen interactions in scrapie. Genetics 79 (Suppl). 387–395 (1975)
Kimberlin, R. H. & Walker, C. A. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 89, 551–562 (1979)
Kimberlin, R. H. & Walker, C. A. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 67, 255–263 (1986)
Czub, M., Braig, H. R. & Diringer, H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J. Gen. Virol. 67, 2005–2009 (1986)
Oesch, B. et al. A cellular gene encodes scrapie Prp 27-30 protein. Cell 40, 735–746 (1985)
Klohn, P., Stoltze, L., Flechsig, E., Enari, M. & Weissmann, C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl Acad. Sci. USA 100, 11666–11671 (2003)
Büeler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577–582 (1992)
Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255–1264 (1996)
Büeler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347 (1993)
Dickinson, A. G., Fraser, H., Meikle, V. M. & Outram, G. W. Competition between different scrapie agents in mice. Nat. New Biol. 237, 244–245 (1972)
Safar, J. et al. Eight prion strains PrPSc molecules with different conformations. Nature Med. 4, 1157–1165 (1998)
Cronier, S. et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem. J. 416, 297–305 (2008)
Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. & Weissmann, C. Darwinian evolution of prions in cell culture. Science 327, 869–872 (2010)
Solforosi, L. et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514–1516 (2004)
Race, R., Raines, A., Raymond, G. J., Caughey, B. & Chesebro, B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J. Virol. 75, 10106–10112 (2001)
Thackray, A. M., Klein, M. A., Aguzzi, A. & Bujdoso, R. Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76, 2510–2517 (2002)
Thackray, A. M., Klein, M. A. & Bujdoso, R. Subclinical prion disease induced by oral inoculation. J. Virol. 77, 7991–7998 (2003)
Asante, E. et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358–6366 (2002)
This work was funded by the UK Medical Research Council. We thank J. Wadsworth for critical review of the manuscript, S. Walker for statistical advice, staff of our Biological Services Facility for animal care and technical assistance and R. Young for preparation of figures.
The authors declare no competing financial interests.
About this article
Cite this article
Sandberg, M., Al-Doujaily, H., Sharps, B. et al. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540–542 (2011). https://doi.org/10.1038/nature09768
Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases
Scientific Reports (2021)
Nature Structural & Molecular Biology (2021)
Veterinary Research (2020)
Nature Structural & Molecular Biology (2020)
Early stage prion assembly involves two subpopulations with different quaternary structures and a secondary templating pathway
Communications Biology (2019)